Global Artemisinin Market Growth 2023-2029

Global Artemisinin Market Growth 2023-2029

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

LPI (LP Information)' newest research report, the “Artemisinin Industry Forecast” looks at past sales and reviews total world Artemisinin sales in 2022, providing a comprehensive analysis by region and market sector of projected Artemisinin sales for 2023 through 2029. With Artemisinin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artemisinin industry.

This Insight Report provides a comprehensive analysis of the global Artemisinin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artemisinin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artemisinin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artemisinin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artemisinin.

The global Artemisinin market size is projected to grow from US$ 61 million in 2022 to US$ 227 million in 2029; it is expected to grow at a CAGR of 227 from 2023 to 2029.

Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.

Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.

In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 80%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.

This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Extraction From Artemisia Annua

Semisynthetic Artemisinin

Segmentation by application

Antimalarial Injections

Antimalarial Tablets

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Sanofi

KPC Pharmaceuticals

Kerui nanhai

Guangxi xiancaotang

Guilin Pharmaceutical

Natural Bio-engineering

BIONEXX

CAT KHANH

BEEPZ

Novanat Bioresource

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artemisinin market?

What factors are driving Artemisinin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artemisinin market opportunities vary by end market size?

How does Artemisinin break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.